Summa Equity
Sweden
- Stockholm, Stockholm County
- 06/12/2022
- Unknown
- $151,000,000
Summa Equity invests in companies that have leading solutions to global challenges and that create positive Environmental, Social, and Governance (ESG) outcomes for society.
We co-create win-win for our investors, our companies, and society through aligning our vision and outcomes to the Sustainable Development Goals, ensuring a net-positive impact against ESG challenges, and the potential for long-term, sustainable outperformance.
We focus on industries and companies within three sustainability megatrends: Resource Efficiency, Changing Demographics, and Tech-Enabled Transformation. Across those themes, our companies are supporting a world which is undergoing a period of transition and showing that business can be part of the solution.
- Industry Venture Capital and Private Equity Principals
- Website https://summaequity.com/
- LinkedIn https://www.linkedin.com/company/summa-equity/
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)